Asimina Mataftsi
Overview
Explore the profile of Asimina Mataftsi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mataftsi A, Moutzouri S, Charonis A, Seliniotaki A, Haidich A, Ziakas N
Ophthalmic Epidemiol
. 2025 Mar;
:1-7.
PMID: 40063848
Purpose: To report the incidence of treatment-requiring retinopathy of prematurity (ROP) in Greece at a national level. Methods: Multicenter prospective cohort study of infants that required treatment for ROP at...
2.
Seliniotaki A, Tziola T, Lithoxopoulou M, Tzamalis A, Ziakas N, Mataftsi A
Graefes Arch Clin Exp Ophthalmol
. 2025 Feb;
PMID: 40011238
Eyedrop instillation constitutes the most commonly used ocular drug delivery method that serves for both diagnostic and therapeutic purposes. Ocular disposition and bioavailability of instilled drugs depend on the anatomy...
3.
Kottaridou E, Seliniotaki A, Mataftsi A, Haidich A, Lithoxopoulou M, Koutra A, et al.
Cureus
. 2025 Jan;
16(12):e76000.
PMID: 39835066
A significant percentage of patients with retinopathy of prematurity (ROP) who progressed to stages 4 and 5 of ROP will require surgical intervention. Scleral buckling surgery is widely employed for...
4.
Seliniotaki A, Lithoxopoulou M, Virgiliou C, Gika H, Dokoumetzidis A, Bougioukas K, et al.
JAMA Ophthalmol
. 2024 Dec;
143(2):110-116.
PMID: 39724200
Importance: Commercial mydriatics administered in preterm infants during retinopathy of prematurity (ROP) screening have been associated with various cardiorespiratory and gastrointestinal adverse events. Objective: To examine whether microdrops of a...
5.
Moutzouri S, Pivodic A, Haidich A, Seliniotaki A, Lithoxopoulou M, Tsakalidis C, et al.
Acta Ophthalmol
. 2024 Nov;
PMID: 39503477
Purpose: To assess the predictive performance of DIGIROP-v1.0 models in identifying treatment-requiring ROP among infants undergoing ROP screening at a tertiary neonatal intensive care unit in Greece. Methods: Retrospective cohort...
6.
Seliniotaki A, Bougioukas K, Lithoxopoulou M, Moutzouri S, Diamanti E, Ziakas N, et al.
Eur J Ophthalmol
. 2024 Mar;
34(6):1803-1809.
PMID: 38445304
Purpose: To compile real-time data on the preferred mydriasis practice patterns for retinopathy of prematurity (ROP) screening in Europe. Methods: A cross-sectional online survey was conducted from December 2022 to...
7.
Moutafi M, Ververi A, Papadopoulou-Legbelou K, Gkiourtzis N, Fotoulaki M, Mataftsi A
Clin Dysmorphol
. 2024 Feb;
33(2):95-98.
PMID: 38411000
No abstract available.
8.
Orfanidou M, Ntenti C, Evripidou K, Mataftsi A, Goulas A, Polyzos S
J Pers Med
. 2023 Jul;
13(7).
PMID: 37511760
This systematic review and meta-analysis aimed to summarize and compare data on retinal vascular lesions between patients with nonalcoholic fatty liver disease (NAFLD) and individuals without the disease. Search was...
9.
Seliniotaki A, Ververi A, Koukoula S, Efstathiou G, Gerou S, Ziakas N, et al.
Ophthalmic Genet
. 2023 Jul;
45(2):159-163.
PMID: 37489109
Background: Inherited retinopathies can initially present with high refractive error in the first decade of life, before accompanying signs or symptoms are evident. Case Presentation: A 4-year-old girl with high...
10.
Chatzistergiou V, Tzamalis A, Diafas A, Oustoglou E, Mataftsi A, Tsinopoulos I, et al.
Int Ophthalmol
. 2023 Apr;
43(9):3139-3148.
PMID: 37097425
Purpose: To assess the repeatability of corneal pachymetry and epithelial thickness measurements with spectral-domain optical coherence tomography (SD-OCT) and identify correlations between epithelial thickness and ocular surface parameters. Methods: Adults...